Allopartis Biotechnologies Inc is categorized under Biological Products Manufacturers in San Francisco, CA and active since 2013.
Allopartis Biotechnologies Inc was established in 2013, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Biological Products Manufacturers business, which does work in the B2B market, and is classified as a Biological Products Manufacturers, under code number 325414 by the NAICS.
If you are seeking more information, feel free to contact Robert Blazej at the company’s single location by writing to 1700 4th St, San Francisco, California CA 94158 or by phoning No number given. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Allopartis Biotechnologies Inc |
| Contact Person: | Robert Blazej |
| Address: | 1700 4th St, San Francisco, California 94158 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2013 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Biological Products Manufacturers |
| SIC Code: | 2836 |
| NAICS Code: | 325414 |
| Share This Business: |
Allopartis Biotechnologies Inc was started in 2013 to provide professional Biological Products Manufacturers under the SIC code 2836 and NAICS code 325414. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Robert Blazej for inquiries that concern Allopartis Biotechnologies Inc by calling the company number No number given, as your correspondence is most welcome. Additionally, the physical location of the single location of Allopartis Biotechnologies Inc can be found at the coordinates 37.767832,-122.391059 as well as the street address 1700 4th St in San Francisco, California 94158.
For its online presence, you may visit Allopartis Biotechnologies Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.